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Introduction
A recent multistate analysis found Maine had the second 
highest average annual increase in opioid use disorder at 
delivery hospitalization since 1999, with 34.1 per 1,000 
deliveries with opioid use disorder in 20121
Purpose  
To estimate the prevalence, characteristics, and 
geographic distribution of delivery hospitalizations with 
opioid use disorder (OUD) among women delivering in 
Maine using more recent state-level data
SMBG and KAA performed this work with funding from the Maine Economic 
Improvement Fund. The authors report no conflicts of interest. 
All analyses were performed using SAS version 9.9 (SAS Institute, Cary, NC) between 
December 2018 and April 2019.
Data Source:
Maine hospital inpatient discharge data provided by the Maine Health Data 
Organization, a state agency that maintains a comprehensive health information 
database for every hospital inpatient encounter in the state.
Reference: 
1 Haight SC, Ko JY, Tong VT, Bohm MK, Callaghan WM. Opioid Use Disorder at 
Delivery Hospitalization – United States, 1999-2014. MMWR Morb Mortal Wkly Rep. 
2018;76(31):845-849.
Methods
• Used International Statistical Classification of 
Diseases and Related Health Problems (ICD) diagnosis 
and procedure codes to identify deliveries among all 
hospital discharges in Maine, 2009-2017
• Categorized deliveries according to prevalence of OUD 
and other substance use, mental health diagnoses, 
and medical conditions - according to maternal 
characteristics and geographic distribution 
• Because our analysis spanned the transition from ICD-
9 to ICD-10 (October 1st, 2015), we used codes from 
both revisions in this analysis
• Ran log-binomial regressions to assess the trends in 
prevalence of OUD at delivery hospitalization over the 
study period 
• Calculated prevalence ratios (PR) and 95% confidence 
intervals (CI) for the co-occurrence of other substance 
use disorders, mental health diagnoses and medical 
conditions among women with OUD as compared with 
women without OUD
• Examined trends in prevalence of OUD at delivery 
hospitalization by county over time, comparing 
deliveries by rural-urban designation of county
Conclusions
• Opioid use disorder among deliveries in Maine has 
increased since 2009, accounting for 1 out of every 30 
deliveries in 2017
• Women with OUD at delivery were more likely to 
experience mental health disorders, other substance 
use, and complications of their substance use than 
women without OUD
• The majority of counties with the highest rates of OUD 
at delivery (5 to <7%) are rural counties in midcoast, 
central and northern Maine
Limitations
• ICD-9 to ICD-10 change at the 3rd quarter of 2015
• Relies on the accuracy of the coding practices of 
medical coders at the inpatient facilities in Maine
• Unable to confirm the presence of the diagnoses and 
procedures examined in this study with chart review
Implications
Continued prevention and treatment of OUD among 
reproductive age women, particularly in rural areas of 
Maine, is needed
Further examination of OUD at delivery hospitalization in 
Maine using linked maternal and infant data is needed to 
inform policy decisions and services provided to women 
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PR 95% CI p-value a
n=3,523 %=3.2 n=105,481 %=96.8
Anxiety 181 5.1 1,999 1.9 2.7 (2.3, 3.1) <.01
Major Depression 142 4.0 1,486 1.4 2.9 (2.4, 3.4) <.01
Alcohol abuse or dependence 30 0.9 92 0.1 9.8 (6.5, 14.7) <.01
Other drug abuse or dependence b 93 2.6 171 0.2 16.3 (12.7, 20.9) <.01
Cannabis use 208 5.9 1,132 1.1 5.5 (4.8, 6.4) <.01
Nicotine use 2,256 64.0 11,277 10.7 6.0 (5.8, 6.2) <.01
Hepatitis  C 268 7.6 228 0.2 35.2 (29.6, 41.9) <.01
• All of the selected mental health diagnoses, other substance use, and 
medical conditions examined were more common (p<.01) among women 
delivering with OUD compared to women delivering without OUD
• 109,004 delivery hospitalizations in Maine from 2009-2017 
• The prevalence of OUD per 1,000 increased from 21.6 in 2009 to 
38.0 per 1,000 in 2017 (linear trend p<.01)
• Average annual increase of 5.8% [95% CI: 4.5%, 7.2%]
• 4 out of 5 of the counties with the highest rates of opioid use disorder at delivery (>50 per 1,000 deliveries) during the 2015 - 2017 period were rural 
counties: Knox, Piscataquis, Somerset, Waldo 
• Penobscot was the only urban county (containing the metropolitan area of Bangor) with a prevalence of OUD at delivery >=50 per 1,000 during the 
study period
Abbreviations: PR, Prevalence ratio; CI, Confidence interval
a Chi-square test p-value comparing deliveries of women with opioid use disorder to deliveries of women without opioid use 
disorder
b Non-opioid and non-alcohol abuse or dependence
2009 - 2011 2012 - 2014 2015 - 2017
Figure 2. Prevalence of opioid use disorder among delivery 
hospitalizations in Maine (n=109,004)
Table 1. Selected maternal conditions among delivery hospitalizations 
in Maine, 2009-2017 
